Introduction & Objective: Pathological adipose tissue remodeling contributed to the development of insulin resistance and type 2 diabetes. The aberrant myeloid phenotype has recently been implicated in driving the diabetic environment. However, the role of myeloid cells in adipose remodeling remains largely unknown.

Methods: C57BL6/J mice were i.p. injected with either Gr-1 or IgG2b isotype control antibody once a week for 2 dose to temporarily eliminate Gr-1+ myeloid cells. Metabolic status was assessed by GTT and ITT. Adipose tissues were harvested for histological, immunostaining, and RNA-seq analysis.

Results: In lean mice, elimination of Gr-1+ cells led to a reduction in gWAT weight. Histologic analysis showed smaller adipocytes, augmented collagen deposition and evaluated expression of a major ECM receptor CD44 in gWAT upon Gr-1 depletion. Ablation of Gr-1+ cells resulted in increased serum level of MCP-1 and more iNOS+CD206 M1 macrophages in gWAT. Interestingly, in spite of no difference was observed in ITT, Gr-1 ablation increased glucose clearance in mice, which was associated with enhanced glycogen deposition in liver and muscle. The KEGG enrichment analysis of RNA-seq data from gWAT revealed that genes with increased expression upon Gr-1 depletion were mainly clustered in regulation of lipolysis in adipocytes, leukocyte transendothelial migration, and ECM-receptor interaction. Besides, GSEA showed a significant enrichment of gene sets associated with TNF signaling pathway, type I diabetes mellitus and insulin resistance.

Conclusion: Acute depletion of Gr-1+ cells promoted the macrophage infiltration and polarization towards a M1 phenotype in gWAT. This pro-inflammatory milieu would contribute to metabolic dysfunction, such as adipose tissue remodeling, aggravated lipolysis and insulin resistance. Our data suggested that Gr-1+ myeloid cell might be a key regulator against pathological adipose tissue remodeling by restricting macrophage infiltration.

Disclosure

Y. Cao: None. J. Cai: None. C. Ji: None.

Funding

The Key Research and Development Program of Jiangsu Province (No. BE2021614); the Outstanding Youth Fund of Nanjing Health Science and Technology Development Project (No. JQX22009).

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.